Overview
Background
Karl Winckel is a conjoint pharmacist working between the School of Pharmacy Unversity of Queensland and the Princess Alexandra Hospital. Karl is an Advanced Practice credentialed pharmacist (stage 3) with clinical pharmacy experience in a wide range of clinical areas including cardiology, general medicine and care of the elderly. However Karl's main interest lies in education and training. Karl has coordinated and continues to coordinate training for doctors, pharmacists and nurses at the Princess Alexandra Hospital, and teaches into undergraduate and postgraduate clinical pharmacy courses at the University of Queensland. Karl co-coordinates 25-28 undergraduate student research project placements per year at the Princess Alexandra Hospital pharmacy department. Karl has co-authored 19 journal article and 1 book chapter in the last 5 years. Karl is also heavily involved in clinical education and training seminars with the Society of Hospital Pharmacists Australia (SHPA). Karl's research interests lie primarily in the clinical use of clozapine, and anticoagulants.
Availability
- Mr Karl Winckel is:
- Available for supervision
Qualifications
- Bachelor of Pharmacy, The University of Queensland
- Postgraduate Diploma, University College London
- Postgraduate Diploma, Aston University
Research impacts
Karl's research around the use of anticoagulants has lead to changes in local guidelines around dosing of anticoagulants on obesity.
Works
Search Professor Karl Winckel’s works on UQ eSpace
2019
Journal Article
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Marteene, Wade, Winckel, Karl, Hollingworth, Sam, Kisely, Steve, Gallagher, Erin, Hahn, Margaret, Ebdrup, Bjørn H, Firth, Joseph and Siskind, Dan (2019). Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety, 18 (12), 1-12. doi: 10.1080/14740338.2019.1674809
2019
Journal Article
Ivabradine in patients with left-ventricular dysfunction and coronary artery disease
Pham, Betty, Winckel, Karl and Snoswell, Centaine L. (2019). Ivabradine in patients with left-ventricular dysfunction and coronary artery disease. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (2), 131-132.
2019
Journal Article
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of Thrombosis and Thrombolysis, 48 (3), 387-393. doi: 10.1007/s11239-019-01847-4
2019
Journal Article
An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia
McArdle, P. A., De Mel, V., DeMonte, V., Winckel, K., Gore-Jones, V., Foley, S., Korman, N., Parker, S., Dark, F. and Siskind, D. (2019). An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. Schizophrenia Research, 206, 450-451. doi: 10.1016/j.schres.2018.11.030
2019
Conference Publication
Dosing intravenous iron: keep it simple
Vongphakdi, M., Winckel, K. and Sullivan, S. (2019). Dosing intravenous iron: keep it simple. SHPA mm2019, Gold Coast, QLD, Australia, 14-16 November 2019.
2019
Conference Publication
Assessing pharmacists adventures in the digital age
Waddell, Jason, House, Lee and Winckel, Karl (2019). Assessing pharmacists adventures in the digital age. In: SHPA MM2019, Gold Coast, QLD Australia, (). 21-22 November 2019.
2019
Conference Publication
The phosphate debate: intravenous vs Oral
Edmonds, M., Winckel, K., Cameron, C. and Powell, H. (2019). The phosphate debate: intravenous vs Oral. Princess Alexandra Hospital (PAH) Health Symposium, Princess Alexandra Hospital (PAH) Brisbane, 31 July 2019.
2019
Conference Publication
The ketone crisis. Drug use evaluation of SGLT2 inhibitors and ketoacidosis
Pinkerton, E., Winckel, K. and Forrester, T. (2019). The ketone crisis. Drug use evaluation of SGLT2 inhibitors and ketoacidosis. SHPA MM2019, Gold Coast, QLD Australia, 14-16 November 2019.
2019
Journal Article
Primary and secondary prevention of stroke
Barras, M.A. and Winckel, K. (2019). Primary and secondary prevention of stroke. Australian Pharmacist, 12, 42-51.
2019
Conference Publication
The appropriateness of rivaroxaban drug level monitoring and the impact on clinical management in patients
Michael, Hayley, Hill, Courtney, Winckel, Karl and Norman Ilich (2019). The appropriateness of rivaroxaban drug level monitoring and the impact on clinical management in patients. SHPA mm2019, Gold Coast, Australia, 14-16 November 2019.
2019
Conference Publication
SGLT21-associated ketoacidosis a growing epidemic: a need for a consumer-friendly infographic
Li, Catherine, Pinkerton, Eve and Winckel, Karl (2019). SGLT21-associated ketoacidosis a growing epidemic: a need for a consumer-friendly infographic. In: SHPA MM2019, Gold Coast, QLD Australia, (). 21-22 November 2019.
2019
Conference Publication
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
Van Oosterom, N., Barras, M. and Winckel, K. (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Princess Alexandra Hospital (PAH) Health Symposium., Brisbane, QLD, Australia, 31 July 2019.
2019
Conference Publication
Final foundation residency portfolio reviews – Feedback from a two-site review process
Woodruff, Gemma, Hendy, Anna, Coombes, Judith, Winckel, Karl, Hale, Andrew, Coombes, Ian and Barras, Michael (2019). Final foundation residency portfolio reviews – Feedback from a two-site review process. APSA 2019, Melbourne, Australia, 1-4 December 2019.
2018
Journal Article
Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)
Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018). Psychopharmacology, 235 (7), 2193-2193. doi: 10.1007/s00213-018-4909-5
2018
Journal Article
Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014
Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology, 235 (7), 1915-1921. doi: 10.1007/s00213-018-4881-0
2018
Journal Article
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine
Siskind, Dan, Friend, Nadia, Russell, Anthony, McGrath, John J., Lim, Carmen, Patterson, Sue, Flaws, Dylan, Stedman, Terry, Moudgil, Vikas, Sardinha, Savio, Suetani, Shuichi, Kisely, Steve, Winckel, Karl and Baker, Andrea (2018). CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ Open, 8 (3) e021000, e021000. doi: 10.1136/bmjopen-2017-021000
2018
Conference Publication
Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial
Siskind, D., Mayfield, K., Winckel, K., Hollingworth, S. and Kisely, S. (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial. SHPA MM2019, Brisbane, Australia, 22-25 November 2019.
2018
Conference Publication
Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital
George, C., Winckel, K., Barras, M., Coombes, J. and Cottrell, N. (2018). Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital. Translational Research Institute Symposium, Brisbane, QLD, Australia, August 2018.
2018
Conference Publication
Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial
Siskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial. 6th Biennial Conference of the Schizophrenia International Research Society (SIRS), Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby016.436
2018
Conference Publication
It's time to re-design safe prescribing education for digital hospitals!
Cheng, Vesa , Forrester, Tori , Hill, Courtney , Slater, Theresa , Winckel, Karl and Coombes, Judith (2018). It's time to re-design safe prescribing education for digital hospitals!. SHPA Medicines Management 2018, Brisbane, Australia, 22-25 November 2018.
Supervision
Availability
- Mr Karl Winckel is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
The Australian Pharmacy Residency Program: What works, for whom, and why
Associate Advisor
Other advisors: Dr Karen Luetsch
Completed supervision
-
2024
Doctor Philosophy
The Australian Pharmacy Residency Program: What works, for whom, and why
Associate Advisor
Other advisors: Dr Karen Luetsch
-
2012
Doctor Philosophy
Pharmacists discussing beliefs about medicines to improve medication adherence: Use of the repertory grid technique in patients post myocardial infarction
Associate Advisor
Other advisors: Professor Lisa Nissen
Media
Enquiries
For media enquiries about Mr Karl Winckel's areas of expertise, story ideas and help finding experts, contact our Media team: